![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
VA Florio and EM Ross
Both adenosine and the P site agent 2',5'-dideoxyadenosine (DDA) reversibly inhibit adenylate cyclase activity in two different preparations of the enzyme that lack the stimulatory guanine nucleotide- binding protein, G/F: plasma membranes from the cyc- variant of S49 lymphoma cells and the resolved catalytic component (C) from rabbit liver. P site agents do not compete with any of the activators of C (Mn2+, G/F, forskolin), nor do they diminish the potency of any activator of C. Rather, activation of C increases the effectiveness of P site agents and causes up to a 10,000-fold increase in the potency of DDA. The ability of G/F or forskolin to potentiate P site inhibition is also noted at concentrations much lower than those required for the stimulation of adenylate cyclase activity. These data are inconsistent with a simple two-state allosteric model for the regulation of the activity of C and demand the postulation of either a distinct, inhibited conformation of the enzyme or the existence of a dead-end complex with adenosine bound to the catalytic site.
This article has been cited by other articles:
|
|
 |
|
  T.-C. Mou, A. Gille, D. A. Fancy, R. Seifert, and S. R. Sprang Structural Basis for the Inhibition of Mammalian Membrane Adenylyl Cyclase by 2 '(3')-O-(N-Methylanthraniloyl)-guanosine 5 '-Triphosphate J. Biol. Chem., February 25, 2005; 280(8): 7253 - 7261. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. K. Sunahara and R. Taussig Isoforms of Mammalian Adenylyl Cyclase: Multiplicities of Signaling Mol. Interv., June 1, 2002; 2(3): 168 - 184. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Onda, Y. Hashimoto, M. Nagai, H. Kuramochi, S. Saito, H. Yamazaki, Y. Toya, I. Sakai, C. J. Homcy, K. Nishikawa, et al. Type-specific Regulation of Adenylyl Cyclase. SELECTIVE PHARMACOLOGICAL STIMULATION AND INHIBITION OF ADENYLYL CYCLASE ISOFORMS J. Biol. Chem., December 14, 2001; 276(51): 47785 - 47793. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Shoshani, V. Boudou, C. Pierra, G. Gosselin, and R. A. Johnson Enzymatic Synthesis of Unlabeled and beta -32P-labeled beta -L-2',3'-Dideoxyadenosine-5'-triphosphate as a Potent Inhibitor of Adenylyl Cyclases and Its Use as Reversible Binding Ligand J. Biol. Chem., December 3, 1999; 274(49): 34735 - 34741. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Doronin, C. Dessauer, and R. A. Johnson Direct Photoaffinity Labeling of Individual Cytosolic Domains of Adenylyl Cyclase by [32P]2'-deoxy-3'-AMP and [alpha -32P]5'-ATP J. Biol. Chem., December 4, 1998; 273(49): 32416 - 32420. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. N. Abell, D. J. McCormick, and D. L. Segaloff Certain Activating Mutations within Helix 6 of the Human Luteinizing Hormone Receptor May Be Explained by Alterations That Allow Transmembrane Regions to Activate Gs Mol. Endocrinol., December 1, 1998; 12(12): 1857 - 1869. [Abstract] [Full Text]
|
|
|
|
|
|
L. Desaubry and R. A. Johnson Adenine Nucleoside 3'-Tetraphosphates Are Novel and Potent Inhibitors of Adenylyl Cyclases J. Biol. Chem., September 18, 1998; 273(38): 24972 - 24977. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. W. Dessauer and A. G. Gilman The Catalytic Mechanism of Mammalian Adenylyl Cyclase. EQUILIBRIUM BINDING AND KINETIC ANALYSIS OF P-SITE INHIBITION J. Biol. Chem., October 31, 1997; 272(44): 27787 - 27795. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. W. Dessauer, T. T. Scully, and A. G. Gilman Interactions of Forskolin and ATP with the Cytosolic Domains of Mammalian Adenylyl Cyclase J. Biol. Chem., August 29, 1997; 272(35): 22272 - 22277. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Johnson, L. Desaubry, G. Bianchi, I. Shoshani, E. Lyons Jr., R. Taussig, P. A. Watson, J. J. Cali, J. Krupinski, J. P. Pieroni, et al. Isozyme-dependent Sensitivity of Adenylyl Cyclases to P-site-mediated Inhibition by Adenine Nucleosides and Nucleoside 3'-Polyphosphates J. Biol. Chem., April 4, 1997; 272(14): 8962 - 8966. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. W. Dessauer and A. G. Gilman Purification and Characterization of a Soluble Form of Mammalian Adenylyl Cyclase J. Biol. Chem., July 12, 1996; 271(28): 16967 - 16974. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Desaubry, I. Shoshani, and R. A. Johnson Inhibition of Adenylyl Cyclase by a Family of Newly Synthesized Adenine Nucleoside 3'-Polyphosphates J. Biol. Chem., June 14, 1996; 271(24): 14028 - 14034. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Désaubry, I. Shoshani, and R. A. Johnson 2`,5`-Dideoxyadenosine 3`-Polyphosphates Are Potent Inhibitors of Adenylyl Cyclases J. Biol. Chem., February 2, 1996; 271(5): 2380 - 2382. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Tang and A. Gilman Construction of a soluble adenylyl cyclase activated by Gs alpha and forskolin Science, June 23, 1995; 268(5218): 1769 - 1772. [Abstract] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
